Current Antimalarial Treatments: Focus on Artemisia annua Dry Leaf
Author:
Open Access
- 5 April 2023
- book chapter
- Published by IntechOpen
Abstract
Since a lot of drugs that were used for the treatment of malaria has shown resistance to the Plasmodium species. Even the ACT (Artemisia combination therapy) is not effective in certain cases. There is a need to look for some alternatives, which are effective in the clinical treatment of malaria and affordable for the general population. A therapy called Artemisia annua dry leaf antimalarial therapy (ALT) has been shown to be effective against artemisinin-resistant malarial infections and its treatment is resilient to resistance development in animal model systems. This proves to be an effective alternative to presently available antimalarials. This review defines the characteristics of different species of malaria-causing parasites, their vectors, endemicity, and features of the disease development, followed by properties of currently used (approved) antimalarials. The choices and methodologies of administration of antimalarials to adult, child, pregnant, and lactating women patients with acute and complicated malaria are described, followed by strategies to combat drug-resistant malaria, especially artemisinin resistance. A special emphasis on the origin, empirical basis, evidence on clinical efficacy, and cost aspects of ALT is given, along with the focus on the possibilities of repurposing ALT as a treatment for a variety of autoimmune, metabolic, and cancerous diseases.Keywords
This publication has 84 references indexed in Scilit:
- A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western KenyaMalaria Journal, 2013
- Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysisMalaria Journal, 2012
- Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Falciparum MalariaAntimicrobial Agents and Chemotherapy, 2011
- Quinine, an old anti-malarial drug in a modern world: role in the treatment of malariaMalaria Journal, 2011
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseasesPhytochemistry Reviews, 2010
- Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in ChildrenAntimicrobial Agents and Chemotherapy, 2010
- Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquineProceedings of the National Academy of Sciences, 2009
- Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2006
- Targeting of Hematin by the Antimalarial PyronaridineAntimicrobial Agents and Chemotherapy, 2006